Crystal Hollenbeck
Psychiatric/Mental Health · Rapid City, SDNPI 1407532138
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 17 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 9 manufacturers reported payments, led by Alkermes, Inc. at 35.2% of the total. 2025 is the largest year on record at $567, 5.9 times the $96 reported in 2023.
Across 17 payments — averaging $49.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alkermes, Inc.$294
- Axsome Therapeutics, Inc.$292
- E.r. Squibb & Sons, L.L.C.$125
- Johnson & Johnson$26
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$23
- Vanda Pharmaceuticals Inc.$22
- plus $54 from 3 others
What the payments were for
- Food & beverage$835100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alkermes, Inc. | 6 | $294 |
| Axsome Therapeutics, Inc. | 4 | $292 |
| E.r. Squibb & Sons, L.L.C. | 1 | $125 |
| Johnson & Johnson | 1 | $26 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $23 |
| Vanda Pharmaceuticals Inc. | 1 | $22 |
| Neurocrine Biosciences, Inc. | 1 | $21 |
| Livanova USA, Inc. | 1 | $19 |
| Lundbeck LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$835 in reported general payments places this provider in the 60th percentile of 77 psychiatric/mental health providers in South Dakota.
See all psychiatric/mental health providers in South Dakota →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Duloxetine Hcl | 35 | $863 |
| Bupropion XlBupropion Hcl | 11 | $274 |
| Buspirone Hcl | 23 | $234 |
| Sertraline Hcl | 28 | $232 |
| Trazodone Hcl | 34 | $217 |
| Quetiapine Fumarate | 16 | $215 |
| Lamotrigine | 16 | $138 |
| Olanzapine | 14 | $87 |
| Clonazepam | 19 | $66 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Rapid City
- Jennifer ErdmanRapid City$6K
- Amy NewstromRapid City$3K
- Kristen CorkleRapid City$2K
- Lisa KautzmanRapid City$2K
- Sydnie GamrothRapid City$1K
- Steven DaryRapid City$1K
- Tamber WhiteRapid City$1K
- Kay FolandRapid City$1K
- Laura SchirberRapid City$1K
- Megan BurgardRapid City$922
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.